NIH Study Supports ER Buprenorphine for OUD in Pregnancy

Originally published by our sister publication Pain Medicine NewsBy PMN StaffA clinical trial supported by the National Institutes of Health has shown weekly administration of injectable extended-release (ER) buprenorphine (Sublocade, Indivior) for the treatment of opioid use disorder (OUD) during pregnancy led to higher rates of abstinence from illicit opioids than a daily sublingual formulation of buprenorphine. Serious adverse events were also less common in ER buprenorphine patients than tho